Action 4164 NAHDI MEDICAL COMPANY
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Nahdi Medical Company

Actions

4164

SA15HG521213

Cours en clôture Saudi Arabian S.E.
Autres places de cotation
 00:00:00 02/05/2024 		Varia. 5j. Varia. 1 janv.
137,8 SAR +0,29% Graphique intraday de Nahdi Medical Company +1,47% +0,58%
18/03 Nahdi Medical Company publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Nahdi Medical Company annonce ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023
Nahdi Medical Posts Higher FY23 Net Profit, Revenue
Nahdi Medical Company Approves Cash Dividend Distribution for the Second Half of 2023
Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
OptiBiotix says market still "volatile" but partner sales improving
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources
Nahdi Medical Company Reports Earnings Results for the Second Quarter Ended June 30, 2023
Nahdi Medical Company Reports Earnings Results for the First Quarter Ended March 31, 2023
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2022
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022
OptiBiotix Health gets approval to sell products in Saudi Arabia
OptiBiotix Health Plc Announces Exclusive Distributor Nahdi Medical Co Has Received Approval from the Saudi Food and Drug Authority for GoFigure Shakes and Bars Containing Patented Weight Management Aid Slimbiome
Nahdi Medical Company Announces the Establishment of a New Company, Owned by its Subsidiaries
Certain Ordinary Shares of Nahdi Medical Company are subject to a Lock-Up Agreement Ending on 20-SEP-2022.
Nahdi Medical Company(SASE:4164) added to S&P Global BMI Index
Nahdi Medical Company(SASE:4164) added to S&P Pan Arab Composite
Nahdi Medical Company Announces Distribution of Cash Dividend for First Half of 2022, Payable on August 25, 2022
Nahdi Medical Company(SASE:4164) added to FTSE All-World Index
Nahdi Medical Company has completed an IPO in the amount of SAR 5.109 billion.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 4164
  4. Actualités Nahdi Medical Company
  5. Autres langues